British Journal of Cancer - Table of Contents alert Volume 119 Issue 5

TABLE OF CONTENTS Volume 119, Issue 5 In this issue Editorial Article Correspondence Also new AOP Editorial The growing importance of radiation worker studies Richard Wakeford British Journal of Cancer 2018 119 :527 - 529; August 15, 2018; 10.1038/s41416-018-0134-6 Abstract | Full Text Article Phase III study of cisplatin with or without S-1 in patients with stage IVB, recurrent, or persistent cervical cancer Yoichi Aoki, Kazunori Ochiai, Soyi Lim, Daisuke Aoki, Shoji Kamiura et al. British Journal of Cancer 2018 119 :530 - 537; August 03, 2018; 10.1038/s41416-018-0206-7 Abstract | Full Text Safety, anti-tumour activity, and pharmacokinetics of fixed-dose SHR-1210, an anti-PD-1 antibody in advanced solid tumours: a dose-escalation, phase 1 study Hongnan Mo, Jing Huang, Jiachen Xu, Xuelian Chen, Dawei Wu et al. British Journal of Cancer 2018 119 :538 - 545; May 14, 2018; 10.1038/s41416-018-0100-3 Abstract | Full Text Routine blood investigations have limited utility in surveillance of aggressive lymphoma in asymptomatic patients in complete remission Eliza A Hawkes, Zoe Loh, Ortis Estacio, Geoff Chong, Francis J Ha et al. British Journal of Cancer 2018 119 :546 - 550; July 23, 2018; 10.1038/s41416-018-0183-x Abstract | Full Text Persistent inequalities in unplanned hospitalisation among colon cancer patients across critical phases of their care pathway, England, 2011–13 Camille Maringe, Bernard Rachet, Georgios Lyratzopoulos & Francisco Javier Rubio British Journal of Cancer 2018 119 :551 - 557; August 15, 2018; 10.1038/s41416-018-0170-2 Abstract | Full Text Trastuzumab and paclitaxel in patients with EGFR mutated NSCLC that express HER2 after progression on EGFR TKI treatment Adrianus J. de Langen, M. Jebbink, Sayed M. S. Hashemi, Justine L. Kuiper, J. de Bruin-Visser et al. British Journal of Cancer 2018 119 :558 - 564; July 31, 2018; 10.1038/s41416-018-0194-7 Abstract | Full Text A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcoma Angiolo Gadducci, Federica Grosso, Giovanni Scambia, Francesco Raspagliesi, Nicoletta Colombo et al. British Journal of Cancer 2018 119 :565 - 571; July 30, 2018; 10.1038/s41416-018-0190-y Abstract | Full Text Significance of re-biopsy for recurrent breast cancer in the immune tumour microenvironment Koji Takada, Shinichiro Kashiwagi, Wataru Goto, Yuka Asano, Katsuyuki Takahashi et al. British Journal of Cancer 2018 119 :572 - 579; July 23, 2018; 10.1038/s41416-018-0197-4 Abstract | Full Text Identification of beta-arrestin-1 as a diagnostic biomarker in lung cancer Victoria El-Khoury, Mélanie Béland, Anna Schritz, Sang-Yoon Kim, Petr V. Nazarov et al. British Journal of Cancer 2018 119 :580 - 590; August 06, 2018; 10.1038/s41416-018-0200-0 Abstract | Full Text MiR-532-5p suppresses renal cancer cell proliferation by disrupting the ETS1-mediated positive feedback loop with the KRAS-NAP1L1/P-ERK axis Wei Zhai, Junjie Ma, Rujian Zhu, Chen Xu, Jin Zhang et al. British Journal of Cancer 2018 119 :591 - 604; August 07, 2018; 10.1038/s41416-018-0196-5 Abstract | Full Text Accreditation, setting and experience as indicators to assure quality in oncology biomarker testing laboratories Véronique Tack, Ed Schuuring, Cleo Keppens, Nils 't Hart, Patrick Pauwels et al. British Journal of Cancer 2018 119 :605 - 614; August 24, 2018; 10.1038/s41416-018-0204-9 Abstract | Full Text Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group David S. Shulman, Kelly Klega, Alma Imamovic-Tuco, Andrea Clapp, Anwesha Nag et al. British Journal of Cancer 2018 119 :615 - 621; August 21, 2018; 10.1038/s41416-018-0212-9 Abstract | Full Text Carbonic anhydrase IX is a pH-stat that sets an acidic tumour extracellular pH in vivo Shen-Han Lee, Dominick McIntyre, Davina Honess, Alzbeta Hulikova, Jesús Pacheco-Torres et al. British Journal of Cancer 2018 119 :622 - 630; September 12, 2018; 10.1038/s41416-018-0216-5 Abstract | Full Text Cancer mortality and incidence following external occupational radiation exposure: an update of the 3rd analysis of the UK national registry for radiation workers Richard G. E. Haylock, Michael Gillies, Nezahat Hunter, Wei Zhang & Mary Phillipson British Journal of Cancer 2018 119 :631 - 637; August 15, 2018; 10.1038/s41416-018-0184-9 Abstract | Full Text Cigarette smoking and thyroid cancer risk: a cohort study Ara Cho, Yoosoo Chang, Jiin Ahn, Hocheol Shin & Seungho Ryu British Journal of Cancer 2018 119 :638 - 645; August 15, 2018; 10.1038/s41416-018-0224-5 Abstract | Full Text Excess body weight, weight gain and obesity-related cancer risk in women in Norway: the Norwegian Women and Cancer study Marisa da Silva, Elisabete Weiderpass, Idlir Licaj, Lauren Lissner & Charlotta Rylander British Journal of Cancer 2018 119 :646 - 656; September 11, 2018; 10.1038/s41416-018-0240-5 Abstract | Full Text Correspondence Comment on 'Impact of NICE guidance on tamoxifen prescribing in England 2011-2017: an interrupted time series analysis' Keith Hopcroft British Journal of Cancer 2018 119 :657 - 657; August 21, 2018; 10.1038/s41416-018-0205-8 Abstract | Full Text Reply to Comment on 'Impact of NICE guidance on tamoxifen prescribing in England 2011–2017: an interrupted time series analysis" Helen Curtis & Ben Goldacre British Journal of Cancer 2018 119 :658 - 658; August 21, 2018; 10.1038/s41416-018-0226-3 Abstract | Full Text Advertisement Nature Briefing is an essential round-up of science news, opinion and analysis, free in your inbox every weekday. With Nature Briefing, we'll keep you updated on the latest research, so you can focus on yours. Click here to sign up. Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. This email has been sent to edgeblog.alerts.2011.001@gmail.com. If you no longer wish to receive the email alerts from British Journal of Cancer click here to unsubscribe . If you wish to discontinue all email services from Nature Research please click here to unsubscribe . For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Macmillan Publishers Limited is a company incorporated in England & Wales under company number 785998 & whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. Nature Research | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature is part of Springer Nature. © 2018 Springer Nature Limited. All rights reserved.